Johnson M A, Yamamoto T, Lee S K. "一种的合成方法" [P]. US Patent, US 9632349 B2, 2024-07-02.
发明人韩伟,冯建国,周伟. "Method for the Synthesis of 1-(4-(6-Chloro-2-methylpyrimidin-4-yl)piperazin-1-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 112529614 B, 授权公告日 2024-09-28.
发明人韩伟,陈志强,郭海燕. "A Process for Preparing High-Purity 1-(4-(6-Chloro-2-methylpyrimidin-4-yl)piperazin-1-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 112328823 B, 授权公告日 2018-11-01.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2015, 2387, 4795-4802.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2021, 2397, 7154-7174.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 1-(4-(6-Chloro-2-methylpyrimidin-4-yl)piperazin-1-yl)ethan-1-one Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 857, (2), 7084-7114.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2019, 1775, (4), 7255-7260.